Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00657917 · ClinicalTrials.gov registry record · Phase 2
Topical Treatment of Recalcitrant Ulcerative Old World Leishmaniasis With WR 279,396
A Phase 2 study, sponsored by U.S. Army Medical Research and Development Command.
- Terminated
- Registry status
- Phase 2
- Development phase
- 1
- Enrollment target
NCT00657917 is a Phase 2 study that was terminated before completion, run by U.S. Army Medical Research and Development Command. The registered enrollment target is 1 participants.
The verdict
NCT00657917, a Phase 2 study, was terminated before completion, sponsored by U.S. Army Medical Research and Development Command.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 1 participants
- Enrollment target
Study Summary
The primary objective of this protocol is to treat laboratory confirmed cutaneous leishmaniasis with WR 279,396 in military health care beneficiaries. In this study "cutaneous leishmaniasis" is defined as Old World Leishmaniasis if acquired in the Southwest Central Asia/Middle East.
Interventions
- DRUG Paromomycin +Gentamicin topical cream
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2006-12-20 |
| Est. Completion | 2010-06-24 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00657917
The ClinicalTrials.gov registry entry for NCT00657917 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is U.S. Army Medical Research and Development Command, which has 77 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Paromomycin +Gentamicin topical cream is the first listed.
NCT00657917 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00657917 about?
NCT00657917 is a clinical study titled "Topical Treatment of Recalcitrant Ulcerative Old World Leishmaniasis With WR 279,396". The primary objective of this protocol is to treat laboratory confirmed cutaneous leishmaniasis with WR 279,396 in military health care beneficiaries. In this study "cutaneous leishmaniasis" is defined as Old World Leishmaniasis if acquired in the Southwest Central Asia/Middle East.
What is the current status of trial NCT00657917?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 1 participants. The study started on 2006-12-20. Estimated completion is 2010-06-24.
What interventions are being tested in trial NCT00657917?
The interventions under investigation include: Paromomycin +Gentamicin topical cream (DRUG).
Who is sponsoring clinical trial NCT00657917?
This trial is sponsored by U.S. Army Medical Research and Development Command, which has 77 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.